eLife | |
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate | |
Ke Huang1  Qian Wen Wang2  Yong Juan Zhao2  Hon Cheung Lee3  Yang Cai3  Chi-Sing Lee4  Zhi Ying Zhao4  Yang Du5  Wan Hua Li5  Hongmin Zhang5  Sujing Wang5  Yun Nan Hou5  Xu Jie Xie5  Wen Jie Zhu5  Sheng Cao5  | |
[1] Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, China;Department of Biology, Southern University of Science and Technology, Shenzhen, China;Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China;Kobilka Institute of Innovative Drug Discovery, School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, China;State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China; | |
关键词: SARM1; fluorescent probes; base-exchange; allosteric inhibitors; CryoEM structure; covalent inhibitors; | |
DOI : 10.7554/eLife.67381 | |
来源: DOAJ |
【 摘 要 】
SARM1 regulates axonal degeneration through its NAD-metabolizing activity and is a drug target for neurodegenerative disorders. We designed and synthesized fluorescent conjugates of styryl derivative with pyridine to serve as substrates of SARM1, which exhibited large red shifts after conversion. With the conjugates, SARM1 activation was visualized in live cells following elevation of endogenous NMN or treatment with a cell-permeant NMN-analog. In neurons, imaging documented mouse SARM1 activation preceded vincristine-induced axonal degeneration by hours. Library screening identified a derivative of nisoldipine (NSDP) as a covalent inhibitor of SARM1 that reacted with the cysteines, especially Cys311 in its ARM domain and blocked its NMN-activation, protecting axons from degeneration. The Cryo-EM structure showed that SARM1 was locked into an inactive conformation by the inhibitor, uncovering a potential neuroprotective mechanism of dihydropyridines.
【 授权许可】
Unknown